Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial.

Autor: Pulsoni A; Hematology, Department of Translational and Precision Medicine, Sapienza University-Polo Pontino, S.M. Goretti Hospital, Latina, Italy. Electronic address: alessandro.pulsoni@uniroma1.it., Ferrero S; Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU 'Città della Salute e della Scienza di Torino', Turin, Italy., Tosti ME; Istituto Superiore di Sanità, National Center for Global Health, Rome, Italy., Luminari S; Hematology Unit, Arcispedale S Maria Nuova, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy; Department CHIMOMO, University of Modena and Reggio Emilia, Reggio Emilia, Italy., Dondi A; Fondazione Italiana Linfomi Onlus (FIL), Modena, Italy., Cavallo F; Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU 'Città della Salute e della Scienza di Torino', Turin, Italy., Merli F; Hematology Unit, Arcispedale S Maria Nuova, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy., Liberati AM; AO Santa Maria Terni, University of Perugia, Perugia, Italy., Cenfra N; Hematology Unit, S Maria Goretti Hospital, AUSL Latina, Latina, Italy., Renzi D; Hematology and Stem Cells Transplantation Unit, IRCCS Istituto Nazionale dei Tumori Regina Elena, Rome, Italy., Zanni M; Division of Hematology, SS Antonio e Biagio Hospital, Alessandria, Italy., Boccomini C; SC Hematology, AOU Città della Salute e della Scienza, Turin, Italy., Ferreri AJM; Lymphoma Unit, IRCCS San Raffaele Scientific Institute, University Vita-Salute San Raffaele, Milan, Italy., Rattotti S; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Zilioli VR; Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Bolis SA; Struttura Complessa di Ematologia, Fondazione IRCCS San Gerardo dei Tintori-Monza, Monza, Italy., Bernuzzi P; Hematology Unit, Department of Onco-Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy., Musuraca G; Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Perrone T; Unit of Hematology with Transplantation, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy., Stelitano C; Department of Hematology, Azienda Ospedaliera Bianchi Melacrinò Morelli, Reggio Calabria, Italy., Tucci A; Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Corradini P; Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy., Bigliardi S; Onco-Hematology Department, Nuovo Ospedale Civile di Sassuolo, Sassuolo, Italy., Re F; Hematology Clinic, AOU di Parma, Parma, Italy., Cencini E; Unit of Hematology, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy., Mannarella C; Hematology Unit, 'Madonna delle Grazie' Hospital, Matera, Italy., Mannina D; Department of Hematology, Azienda Ospedaliera Papardo, Messina, Italy., Celli M; Hematology, Ospedale degli Infermi, Rimini, Italy., Tani M; Hematology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy., Annechini G; Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Assanto GM; Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Grapulin L; Department of Radiotherapy, AOU Policlinico Umberto I, Rome, Italy., Guarini A; Hematology, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Cavalli M; Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., De Novi LA; Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Bomben R; Clinical and Experimental Onco-Hematology Unit, CRO Aviano National Cancer Institute, Aviano, Italy., Ciabatti E; Section of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Genuardi E; Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU 'Città della Salute e della Scienza di Torino', Turin, Italy., Drandi D; Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU 'Città della Salute e della Scienza di Torino', Turin, Italy., Della Starza I; Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy; AIL Roma, ODV, Rome, Italy., Arcaini L; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Molecular Medicine, University of Pavia, Pavia, Italy., Ricardi U; Radiation Oncology, Department of Oncology, University of Turin, Turin, Italy., Gattei V; Clinical and Experimental Onco-Hematology Unit, CRO Aviano National Cancer Institute, Aviano, Italy., Galimberti S; Section of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Ladetto M; Department of Translational Medicine, SCDU Ematologia AO SS Antonio e Biagio E Cesare Arrigo, Università del Piemonte Orientale, Alessandria, Italy., Foà R; Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Del Giudice I; Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. Electronic address: ilaria.delgiudice@uniroma1.it.

Publikováno v: The Lancet. Haematology [Lancet Haematol] 2024 Jul; Vol. 11 (7), pp. e499-e509.

ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings.

Autor: Chiaretti S; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Taherinasab A; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Della Starza I; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy.; Fondazione GIMEMA Onlus, Rome, Italy., Canichella M; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Ansuinelli M; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., De Propris MS; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Messina M; Fondazione GIMEMA Onlus, Rome, Italy., Spinelli O; Haematology and Bone Marrow Transplant Unit, ASST-Papa Giovanni XXIII, Bergamo., Santoro A; Department of Hemato Oncology, AOR 'VillaSofia-Cervello', Palermo, Italy., De Novi LA; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Cardinali D; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy., Schipani M; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Arena V; Fondazione GIMEMA Onlus, Rome, Italy., Bassan R; Division of Hematology, Ospedale dell'Angelo, Mestre, Venezia, Italy., Guarini A; Department of Molecular Medicine, 'Sapienza' University of Rome, Italy., Foà R; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University of Rome, Rome, Italy.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2023 Feb; Vol. 64 (2), pp. 483-486. Date of Electronic Publication: 2022 Dec 19.

Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia.

Autor: Della Starza I; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Via Benevento 6, 00161 Rome, Italy.; GIMEMA Foundation, 00182 Rome, Italy., De Novi LA; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Via Benevento 6, 00161 Rome, Italy., Elia L; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Via Benevento 6, 00161 Rome, Italy., Bellomarino V; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Via Benevento 6, 00161 Rome, Italy., Beldinanzi M; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Via Benevento 6, 00161 Rome, Italy., Soscia R; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Via Benevento 6, 00161 Rome, Italy., Cardinali D; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Via Benevento 6, 00161 Rome, Italy., Chiaretti S; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Via Benevento 6, 00161 Rome, Italy., Guarini A; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Via Benevento 6, 00161 Rome, Italy., Foà R; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Via Benevento 6, 00161 Rome, Italy.

Publikováno v: Cancers [Cancers (Basel)] 2023 Jan 06; Vol. 15 (2). Date of Electronic Publication: 2023 Jan 06.

Donor cell derived mantle cell lymphoma in a HSCT sibling donor-recipient pair: intrinsic biological clock in lymphomagenesis.

Autor: Musiu P; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Quattrocchi L; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Barberi W; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Della Starza I; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Elia L; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., De Novi LA; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Petrucci L; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., De Luca G; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Di Rocco A; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., La Rocca U; Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2022 Feb; Vol. 63 (2), pp. 499-502. Date of Electronic Publication: 2021 Oct 25.

Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network.

Autor: Mantoan B; Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Italy., Genuardi E; Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Italy., Ferrante M; Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Italy., Della Starza I; Hematology, Department of Translational and Precision Medicine, Sapienza University of Roma, Italy.; Gimema Foundation, Rome, Italy., Ciabatti E; Division of Hematology, Department of Clinical and Experimental Medicine, Santa Chiara Hospital, Pisa, Italy., Grassi S; Division of Hematology, Department of Clinical and Experimental Medicine, Santa Chiara Hospital, Pisa, Italy., De Novi LA; Hematology, Department of Translational and Precision Medicine, Sapienza University of Roma, Italy., Cavalli M; Hematology, Department of Translational and Precision Medicine, Sapienza University of Roma, Italy., Mannu C; Hematopathology section, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Italy., Gazzola A; Hematopathology section, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Italy., Bomben R; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano, Italy., Degan M; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano, Italy., Alessandria B; Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Italy., Pott C; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany., Delfau-Larue MH; Laboratoire d'immunologie biologique, hôpital Henri-Mondor, Créteil Cedex, France., García-Sanz R; Division of Hematology, Servicio de Hematología, Hospital Universitario de Salamanca, Spain., Agostinelli C; Hematopathology section, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Italy., Gattei V; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano, Italy., Galimberti S; Division of Hematology, Department of Clinical and Experimental Medicine, Santa Chiara Hospital, Pisa, Italy., Del Giudice I; Hematology, Department of Translational and Precision Medicine, Sapienza University of Roma, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Ladetto M; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.; SC Ematologia and Infrastruttura Ricerca Formazione Innovazione, Az Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Ferrero S; Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Italy.; Hematology U, 'AOU Città della Salute e della Scienza di Torino,' Italy., Drandi D; Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Italy.

Publikováno v: HemaSphere [Hemasphere] 2021 Sep 06; Vol. 5 (10), pp. e639. Date of Electronic Publication: 2021 Sep 06 (Print Publication: 2021).